Most of us know that medicines carry risks as well as rewards, but just how are they monitored?

‍

‍

This presentation by the European Medicines Agency does a fantastic job of explaining, in a straightforward way, how the safety of new covid19 drugs are monitored and recorded throughout each step of the drugdevelopment process.

—

Providing a full suite of pharmaceutical services for over two decades, QUINTA-ANALYTICA are market-leaders in drug testing, clinical studies, bioanalytical services & more.

Get in toush with us today to discuss how we can help support you.

‍

Additional News

  • 18 July 2023

    Challenges of a large-scale study of breast cancer

    Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.

  • 29 June 2023

    EU funding for Quinta-Analytica laboratory in Brno (CZ) was succesfully completed.

    After two years, the project to finance new equipment for the Quinta-Analytica laboratory in Brno was successfully completed. The investment from European Regional Development Fund was used in this project.

  • 22 June 2023

    Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies

    EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency

ALL POSTS